Sebaceous Gland Abnormalities in Fatty Acyl CoA Reductase 2 (Far2) Null Mice Result in Primary Cicatricial Alopecia

    October 2018 in “ PloS one ”
    John P. Sundberg, Tong Shen, Oliver Fiehn, Robert H. Rice, Kathleen A. Silva, Victoria E. Kennedy, Nicholas E. Gott, Louise Dionne, Lesley Bechtold, Stephen A. Murray, Raoul Kuiper, C. Herbert Pratt
    Image of study
    TLDR Deleting the Far2 gene in mice causes sebaceous gland issues and patchy hair loss.
    The study on Far2 null mice revealed that the deletion of the fatty acyl CoA reductase 2 (Far2) gene led to primary cicatricial alopecia characterized by sebaceous gland abnormalities and patchy hair loss. These mice exhibited significant histologic changes, including follicular dystrophy, rupture, and trichogranuloma formation. Lipidomic analysis showed altered skin surface lipid profiles, with decreased levels of wax esters and unsaturated fatty acids, and increased levels of saturated fatty acids, triacylglycerols, and ceramides. The findings suggested that Far2 is crucial for maintaining normal sebaceous gland function and hair follicle integrity, and that altered sebum homeostasis played a significant role in the pathogenesis of primary cicatricial alopecia.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    6 / 282 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  136 upvotes 7 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community We need to keep these snake oil companies accountable.

      in Treatment  121 upvotes 5 months ago
      Biotin is being misleadingly marketed as a primary treatment for androgenic alopecia, overshadowing more effective treatments like finasteride and minoxidil. There is a call for increased awareness and accountability to prevent misinformation.

    Related Research

    2 / 2 results